Stuka Paul 4

What Happened Stuka Paul, a director of InspireMD, reported an open-market purchase of 20,000 common shares on 2026-05-27. The filing reports a weighted-average price of $0.88 per share and a total reported acquisition value of $17,500. This was a purchase (potentially a positive signal), not a sale or option exercise.

Key Details

• Transaction date: 2026-05-27; filing date: 2026-05-29 (filed within the typical 2-business-day window).
• Price: reported weighted average $0.88; purchases occurred at prices ranging $0.87–$0.88 (per footnote).
• Shares acquired: 20,000; reported total value: $17,500 (as stated in the filing).
• Shares owned after transaction: Not specified in this Form 4.
• Footnotes of note:
  • F1: Weighted-average price reflects multiple trades; reporting person can provide breakdown on request.
  • F2: Some securities are held by Osiris Investment Partners, L.P.; the reporting person is the managing member of the general partner and disclaims beneficial ownership except for any pecuniary interest.
• Transaction code: P = Purchase (open-market).

Context Director purchases can be of interest to retail investors as one datapoint about insider sentiment, but a single small-dollar purchase ($17.5k) is not definitive. This was a straightforward open-market buy (no option exercise, grant, or gift). Watch for additional filings that might show follow-up activity or clarify post-transaction holdings.